Two Sigma Investments’s Quest Diagnostics DGX Stock Holding History

Two Sigma Investments’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,100	Closed	-$3.48M	–	3072
2021 Q4	$3.48M	Buy	20,100 +10,100	+101%	+$1.54M	0.01%	1453
2021 Q3	$1.45M	Sell	10,000 -3,400	-25%	-$497K	﹤0.01%	2277
2021 Q2	$1.77M	Buy	13,400 +6,000	+81%	+$786K	﹤0.01%	1975
2021 Q1	$950K	Buy	7,400 +5,500	+289%	+$678K	﹤0.01%	2375
2020 Q4	$226K	Hold	1,900	–	–	﹤0.01%	3049
2020 Q3	$218K	Sell	1,900 -2,400	-56%	-$284K	﹤0.01%	2770
2020 Q2	$490K	Buy	+4,300	New	+$456K	﹤0.01%	2008
2020 Q1	–	Sell	-2,100	Closed	-$224K	–	3257
2019 Q4	$224K	Buy	+2,100	New	+$219K	﹤0.01%	3365
2019 Q3	–	Sell	-17,000	Closed	-$1.73M	–	3518
2019 Q2	$1.73M	Buy	+17,000	New	+$1.63M	0.01%	1538
2018 Q2	–	Sell	-45,000	Closed	-$4.51M	–	3380
2018 Q1	$4.51M	Buy	+45,000	New	+$4.61M	0.02%	1013
2016 Q4	–	Sell	-23,300	Closed	-$1.97M	–	3176
2016 Q3	$1.97M	Buy	+23,300	New	+$1.96M	0.01%	1468

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Two Sigma Investments's DGX Position: Q1 2026 in Review

Two Sigma Investments sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 47,984 shares — an estimated $8.33M sold.

Two Sigma Investments first reported a position in DGX in Q4 2013 and held it in 33 quarters. The position peaked at $95.7M in Q4 2018. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Two Sigma Investments reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
Two Sigma Investments sold 47,984 Quest Diagnostics shares in Q1 2026, an estimated $8.33M.
Two Sigma Investments first reported a position in Quest Diagnostics in Q4 2013 and held it in 33 quarters.
Two Sigma Investments's Quest Diagnostics position peaked at $95.7M in Q4 2018.
1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.